Specialty Pharmacy

Immunotherapies have improved survival in cancer patients.

While incidences of metastatic breast cancer are increasing, so is survival.

Scientists redesigned a portion of rituximab into a new molecule to treat amyotrophic lateral sclerosis.

A compound in aged cheese, mushrooms, and whole grains found to increase life span by 25% in animal models.

Top news of the day from across the health care landscape.

Cheryl Allen, vice president of Industry Relations at Diplomat Specialty Pharmacy, discusses the elements of an effective, high touch patient care program.

Patients with HIV can now expect to live into old age, and therefore need links to the community health network.

Isentress HD is a once daily treatment for HIV-1 that helps patients achieve viral suppression.

GLUT1 inhibitors could be a potential therapeutic target for the squamous subtype of cancer.

Tocilizumab (Actemra) is the first drug approved to treat giant cell arteritis.

Leader and follower cells depend on each other for survival and invasion.

Top news of the day from across the health care landscape.

Sheila Arquette, RPh, discusses optimal patient support programs in specialty pharmacy.

Surgeries that address colorectal cancer, ulcerative colitis, Crohn's disease, mechanical bowel obstruction and recurrent diverticulitis are often a necessity.

A how-to guide for pharmacy school students interested in pursuing a career in specialty pharmacy.

A cancer diagnosis can cause up to a 3.5% reduction in earnings for men and up to 6% for women.

Ceritinib (Zykadia) approved to treat anaplastic lymphoma kinase-positive metastatic non-small cell lung cancer.

Carboplatin plus birinapant effective against high-grade serious ovarian cancer.

Fampyra significantly improved walking and enhanced quality of life in patients with multiple sclerosis.

Top news of the day from across the health care landscape.

Patient genotypes of in both hepatitis C and advanced cirrhosis may help predict outcomes with direct-acting antiviral drugs.

Imaging technology highlights cancerous features of a breast tumor.

Top articles of the week from The American Journal of Pharmacy Benefits.

Study will assess improvements in mobility and changes in disability in patients with MS.

Early microbial changes may identify patients most likely to achieve and maintain treatment response.

Novel strategy prolongs immune system defense against HIV.

Novel combination may improve treatment options for castration resistant prostate cancer.

New diagnoses of squamous cell carcinoma increased 263% and basal cell carcinoma increased 145%.